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Introduction: While amnestic mild cognitive impairment (aMCI) and non-amnestic mild
cognitive impairment (naMCI) are theoretically different entities, only a few investigations
studied the structural brain differences between these subtypes of mild cognitive
impairment. The aim of the study was to find the structural differences between aMCI
and naMCI, and to replicate previous findings on the differentiation between aMCI and
healthy controls.
Methods: Altogether 62 aMCI, naMCI, and healthy control subjects were included into
the study based on the Petersen criteria. All patients underwent a routine brain MR
examination, and a detailed neuropsychological examination.
Results: The sizes of the hippocampus, the entorhinal cortex and the amygdala were
decreased in aMCI relative to naMCI and to controls. Furthermore the cortical thickness of
the entorhinal cortex, the fusiform gyrus, the precuneus and the isthmus of the cingulate
gyrus were significantly decreased in aMCI relative to naMCI and healthy controls. The
largest differences relative to controls were detected for the volume of the hippocampus
(18% decrease vs. controls) and the cortical thickness (20% decrease vs. controls) of the
entorhinal cortex: 1.6 and 1.4 in terms of Cohen’s d. Only the volume of the precuneus
were decreased in the naMCI group (5% decrease) compared to the control subjects:
0.9 in terms of Cohen’s d. Significant between group differences were also found in
the neuropsychological test results: a decreased anterograde, retrograde memory, and
category fluency performance was detected in the aMCI group relative to controls
and naMCI subjects. Subjects with naMCI showed decreased letter fluency relative to
controls, while both MCI groups showed decreased executive functioning relative to
controls as measured by the Trail Making test part B. Memory performance in the aMCI
group and in the entire sample correlated with the thickness of the entorhinal cortex and
with the volume of the amygdala.
Conclusion: The amnestic mild cognitive impairment/non-amnestic mild cognitive
impairment separation is not only theoretical but backed by structural imaging methods
and neuropsychological tests. A better knowledge of the MCI subtypes can help to
predict the direction of progression and create targeted prevention.
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INTRODUCTION
Major neurocognitive disorders (NCD) or dementia including
Alzheimer’s disease (AD) are a devastating problem of our
aging society having tremendous social, economic and medical
burden. Since we do not have effective treatment for NCD at
the moment, recent research have focused on the detection of
early symptoms. Converging evidence from many recent studies
revealed that pathologic process of AD starts decades prior
to the first symptoms of cognitive decline (Mattsson et al.,
2009). The intermediate stage between the expected cognitive
decline in physiological aging and the severe decline in dementia
known as “mild cognitive impairment” (MCI) has gained a lot
of interest. “In MCI mild impairment of cognitive skills can
be revealed by neuropsychological tests, while global cognitive
functions and everyday activities are preserved” (Petersen, 2004).
The higher conversion rate to NCD in MCI gives the clinical
significance of this pre-disease condition. Conversion rate to
NCD is 10–15% annually in MCI compared to the annual
rate of 1–4% in the average elderly population (Petersen et al.,
2001; Bischkopf et al., 2002).The majority of these patients
develop clinical AD. It should be noted that MCI could be also
a stable or reverse condition not progressing into dementia.
Longitudinal epidemiologic studies reported variant conversion
rate and a relatively frequent reversion to normal cognition
(Larrieu et al., 2002; Ganguli et al., 2004). Different findings
suggest instability in the diagnostic accuracy and a need for
more specific identification between the MCI patients (Han et al.,
2012). In view of the above it is understandable that several
studies target the symptoms and differences from the average
population that are closely linked to the development of dementia
and can therefore be used to assist the early diagnosis.
Patients with MCI can be categorized further as amnestic
(aMCI) and non-amnestic MCI (naMCI). In aMCI the memory
loss is predominant and it is associated with high risk to further
conversion to AD (Grundman, 2004). Individuals with naMCI
have impairments in other domains than memory and have a
higher risk to convert to other dementia forms such as diffuse
Lewy body dementia. Both types can be categorized further
to single-domain and multi domain subtypes, however in the
present investigation no further categorization was done due to
the limited sample size. Significant types of biomarkers of MCI
have been tested with the aim to identify the special features
of patients conversing into AD. While results of cerebrospinal
fluid biomarkers (Hansson et al., 2006) and positron emission
tomography studies (Mosconi et al., 2004) pointed out highly
variant specificity and sensitivity, structural magnetic resonance
imaging studies revealed impressive results (Jack et al., 1999;
deToledo-Morrell et al., 2004). Interestingly, several previous
studies investigated the differences between subjects with MCI
and healthy controls, only a few studies tried to differentiate
between the MCI subtypes (Zhang et al., 2011; Serra et al., 2013).
While aMCI and naMCI are theoretically different entities,
only a few investigations studied the structural brain differences
between these subtype of MCI (Serra et al., 2013). The aim of the
study was to find the structural differences between aMCI and
naMCI, and to replicate previous findings on the differentiation
between aMCI and healthy controls. Based on previous studies on
MCI and conversion to dementia we focused on structures of the
temporal lobe and the neighboring regions (Chiang et al., 2011):
the entorhinal cortex, the hippocampus, the parahippocampal
cortex, the amygdala, the fusiform gyrus, the precuneus, the
posterior cingulate cortex, and the isthmus of cingulate gyrus.
METHODS
This study is a continuation of our previously published work
(Sirály et al., 2015). Since a similar neuropsychological test
battery, and the same MRI acquisition and processing pipeline
has been used in the present study, methods and procedures have
been described similarly in both papers.
Ethics Statement
The experiments were conducted in full compliance with the
Helsinki Declaration and all relevant national and international
ethical guidelines. The research was approved by the National
Ethics Committee, Budapest, Hungary. All procedures were
carried out only after written informed consent was obtained
from the participants. All potential participants who declined
to participate or otherwise did not participate were not
disadvantaged in any way by not participating in the study.
Participants
The study was carried out in the Department of Psychiatry and
Psychotherapy, Semmelweis University, Budapest. Altogether 62
subjects were enrolled in the study. All subjects applied to
participate in a cognitive training program announced among
general practitioners and in a Retirement Home (The study is
registered at ClinicalTrials.gov, identifier is “NCT02310620”). All
subjects were able to lead independent lives. Basic demographic
and neuropsychological data are summarized in Table 1.
Subjects with aMCI and naMCI, and healthy controls
were included into the study based on the Petersen criteria
(Petersen, 2004). The Petersen criteria include subjectivememory
complaint corroborated by an informant together with preserved
everyday activities, a memory impairment based on a standard
neuropsychological test, preserved global cognitive functions
and finally the exclusion of dementia. It does not specify
a neuropsychological test for the assessment of memory
impairments, therefore we applied the Rey Auditory Verbal
Learning Test (RAVLT), which is the most frequently used
test based on the literature (Gomar et al., 2011). For the
differentiation between aMCI and healthy controls we applied
a cutoff score of 1 SD under population mean standardized
for age and gender. Participants, who scored under the cutoff
value either in the delayed recall subscore or in the total score,
was put into the aMCI group. The applied criteria are based
on the recommendations of the National Institute on Aging—
Alzheimer’s Association workgroups on diagnostic guidelines
for Alzheimer’s disease (Albert et al., 2011). The exact cutoff
scores for the RAVLT for the different age groups are provided
in Table 2A. Subjects who were not in the aMCI group, but
scored 1 SD under the population mean standardized for age
and gender/education either in the Trail making Test B or
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TABLE 1 | Demographic data and result of basic neuropsychological tests.
Control (n = 24) naMCI (n = 18) aMCI (n = 20) p-value
Age 65.4 (7.6) 70.9 (7.3) 70.9 (11.3) n.s.*
Educationa 4%/38%/58% 11%/28%/61% 15%/25%/60% n.s.*
Gender (Female) 71% 61% 60% n.s.*
Rey Auditory Verbal Learning Test 1–5 sumb 53.2 (8.1) 47.1 (9.9) 29.6 (7.3) p < 0.0001
ACE Total Scorec 94.0 (3.3) 89.1 (5.1) 82.2 (7.4) p < 0.0001
ACE VL/OM-ratiod 2.6 (0.4) 2.5 (0.4) 3.1 (0.8) p = 0.003
Mini mental state examination total scoree 28.5 (1.4) 28.3 (1.0) 27.5 (1.7) n.s.*
Geriatric depression scale scoref 3.2 (2.7) 5.0 (2.8) 4.1 (3.2) n.s.*
STAI scoreg 37.3 (10.4) 37.1 (9.3) 35.9 (8.4) n.s.*
aMCI, Amnestic mild cognitive impairment; naMCI, non-amnestic mild cognitive impairment, ACE, Addenbrooke’s Cognitive Examination; STAI, state-trait anxiety inventory.
aParticipants were categorized into three education groups: 1, ≤ 12 years; 2, high school graduation (12 years education); 3, more than 12 years education.
bSum of all words in the first five trials. The maximum score is 75. Normative data can be found in Table 2A.
cThe maximum score is 100.
dVL/OM: verbal fluency and language points/orientation and delayed recall ratio can be defined based on ACE. Result below 2,2 indicate frontotemporal dementia and result over 3,2
indicate Alzheimer’s disease.
eThe maximum score is 30. Normative data can be found in the Table 2B.
fThe maximum score is 15.
gState-Trait Anxiety Inventory. The maximum score is 80.
*n.s. (not significant) = p > 0.05.
in the Addenbrooke’s Cognitive Examination (ACE), were put
in the naMCI group. An additional criterion for the naMCI
group was a lower than 3.2VLOM (verbal fluency + language
score/orientation + memory score) ratio in the ACE to exclude
possible aMCI subjects from the naMCI group (these subjects
were excluded from the study).
Subjects with dementia were excluded from the study
according to the Mini Mental State Examination (MMSE)
scores standardized for age and education (Strauss et al.,
2006b). The exact cutoff scores for the MMSE in the
different age and education groups are provided in Table 2B.
Subjects with history of head trauma, epilepsy or stroke,
or diagnosis of acute psychiatric disorder, schizophrenia or
mania, alcohol dependency were also excluded from the
study.
MR Image Acquisition and Processing
All subjects were examined by brain MRI producing high
resolution structural images, which were used for further
processing and analysis. Image acquisitions were done at
the MR Research Center, Semmelweis University, Budapest
on a 3 Tesla Philips Achieva clinical MRI scanner equipped
with an eight-channel SENSE head-coil. The high resolution,
whole brain anatomical images were obtained using a T1
weighted 3 dimensional spoiled gradient echo (T1W 3D TFE)
sequence. 180 contiguous slices were acquired from each
subject with the following imaging parameters: TR = 9.7ms;
TE = 4.6ms; flip angle = 8◦; FOV of 240 × 240mm; voxel size
of 1.0 × 1.0 × 1.0mm.
Cortical reconstruction and volumetric segmentation were
performed by Freesurfer 5.3 image analysis suite, which is
documented and freely available for download online (http://
surfer.nmr.mgh.harvard.edu/). The technical details of these
procedures are described in prior publications, we made no
changes to this pipeline. Briefly, image processing includes
motion correction (Reuter et al., 2010), removal of non-brain
tissue using a hybrid watershed/surface deformation procedure
(Segonne et al., 2004), automated Talairach transformation,
segmentation of the subcortical white matter, and deep
gray matter volumetric structures (including hippocampus,
amygdala, caudate, putamen, ventricles) (Fischl et al., 2004)
intensity normalization, tessellation of the gray matter white
matter boundary, automated topology correction, and surface
deformation following intensity gradients to optimally place the
gray/white and gray/cerebrospinal fluid borders at the location
where the greatest shift in intensity defines the transition to
the other tissue class (Dale et al., 1999; Fischl and Dale, 2000).
Once the cortical models were completed, Freesurfer performed
a number of deformable procedures for in further data processing
and analysis. Steps included surface inflation (Fischl et al., 1999a),
registration to a spherical atlas which utilized individual cortical
folding patterns to match cortical geometry across subjects
(Fischl et al., 1999b), parcellation of the cerebral cortex into
units based on gyral and sulcal structure (Fischl et al., 2004),
and creation of a variety of surface based data including maps of
curvature and sulcal depth. Finally cortical models and the results
of segmentation were quality checked and manually corrected on
each subject, however correction showed no significant changes
to the results.
Procedures
The neuropsychological examinations were carried out on
weekdays between 8 a.m. and 4 p.m. The examinations
consisted of computerized (i.e., PAL test) and paper based
neuropsychological tests. The tests took place in a separate
well-lit room where only the patient and an examiner were
present. Reference tests were also completed and evaluated
according to the recommendations of the Neuropsychological
Compendium (Strauss et al., 2006a), while the computerized tests
were evaluated by the software.
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TABLE 2 | (A). Rey Auditory Verbal Learning Test (RAVLT): normative data and cut-off scores for Mild Cognitive Impairment (MCI) adjusted for age; (B)
Mini Mental Examination Test (MMSE): cut-off scores for dementia adjusted for age and education.
(A)
Age groups 50–59 60–69 70+
Total score (sum of trials 1–5)a Mean (SD) 47.6 (8.1) 43.4 (7.7) 37.1 (7.5)
Cutoff score 39 35 29
Delayed Recallb Mean (SD) 9.9 (3.2) 8.8 (3.0) 7.0 (2.4)
Cutoff score 6 5 4
(B)
Education Groups Age groups 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85 +
5–8 years Cutoff score 23 23 23 23 23 21 21 17
9–12 years or high school diploma Cutoff score 25 25 25 25 24 24 21 21
College experience or higher degree Cutoff score 27 27 27 27 25 25 25 24
aThe summarized number of learned words in the first five trial. The maximum score in this subtest is 75.
bThe number of recalled words after 20–30min. The maximum score on this subtest is 15.
SD: standard deviation.
Neuropsychological tests were administered by two previously
trained medical students under the supervision of a psychologist
and a psychiatrist. During the assessment of the tests the
guidelines of the Neuropsychological Compendium (Strauss
et al., 2006a) were followed. The paper based tests were evaluated
by the same psychologist and a psychiatrist according to the
compendium. The Paired Associates Learning Test (PAL test)
were evaluated automatically by a software. MR data were also
analyzed and evaluated automatically by the Freesurfer and SAS
software; therefore no subjective judgments were involved in
the analysis of neuroimaging data. Since the assessment and
evaluation of the PAL test, and neuroimaging data were totally
automatic, the bias from human judgments were low (limited
only to the evaluation of the paper based tests).
Subjects with dementia were excluded from the study based
on the Mini Mental State Examination (MMSE). The MMSE is a
standard test; its effectiveness was proven by several studies, as a
useful method in differentiating between subjects with dementia
and healthy controls (Petersen et al., 1999; Gomar et al., 2011).
The majority of the previous studies used the cut off score of 26
or the age adjusted score for dementia. The subtasks of the test
assess orientation, central executive function, rapid association
formation, verbal identification ability, and the ability to analyze
and synthesize.
The Addenbrooke’s Cognitive Examination was used to
assess the global cognitive performance, including orientation,
attention, memory, verbal fluency, verbal, and visuospatial skills
(Mathuranath et al., 2000; Alexopoulos et al., 2010).
The Rey Auditory Verbal Learning Test was used for the
detailed assessment of memory functions based on Petersen
criteria. Rey test evaluates verbal learning and memory (Rey,
1958). A list of 15 words (list A) should be repeated by the subject
immediately. This test is repeated 5 times. Then another list of
15 words (list B or interference list) is presented once that should
be recalled. Then list A should be recalled without repeating, and
then this task is repeated after 30min.
The Trail Making test, Part A and Part B (number connection;
REITAN, 1955; Tombaugh, 2004; Alexopoulos et al., 2010) is
used to evaluate selective attention, executive functions, and
cognitive flexibility. In Part A, randomly distributed numbers
should be connected in numerical order, while in Part B
randomly distributed numbers and letters are displayed. The
subject is instructed to connect the numbers and letters in a pre-
defined order. The dependent variable is the time required to
complete the test. Part A of TMT measures executive functions
and attention, while in the performance on Part B cognitive
flexibility is also reflected.
The results of the neuropsychological tests are summarized in
Table 1.
All participants completed a form in which they evaluated
their own health condition and memory function; furthermore,
they had to report on their computer and internet use,
recreational activities, alcohol consumption, dietary habits, and
smoking (Yesavage, 1988). The Geriatric Depression Scale (GDS)
was used to assess depressive symptoms, while anxiety symptoms
were measured by the Spielberger State-Trait Anxiety Inventory
(STAI; Spielberger et al., 1970).
Visuospatial memory was measured by an implementation
of the PAL test used in several neuropsychological test batteries
(Siraly et al., 2013). “In the PAL test windows open up in
random positions on the screen after each other for 3 s with
abstract shapes shown in one or more windows. Other windows
remain blank depending on the difficulty level. When all squares
were shown, the previously shown shapes appear in the center
of the screen and the participants have to decide in which
window they saw that shape before. The test consist of five
different levels in eight stages in total, the number of shapes
increases from 1 to 8 on the different stages. The subjects
had 10 trials to complete a given stage, otherwise the test
ended. The arrangement of windows was asymmetrical in the
test and it changed from stage to stage.” (Siraly et al., 2013)
During the computerized test subjects were seated comfortably
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at a distance of half a meter from the computer screen and
following prior information they solved the tasks with the use of
a mouse.
Statistical Analysis
Differences between study groups in brain volumes, cortical
thickness and cognitive performance were analyzed by General
Linear Model Analysis (GLM in SAS 9.2) with age and gender
as covariates. Volumes were standardized for total intracranial
volume (TIV), and are given in percentage. In order to analyze
between group differences post hoc t comparisons were applied,
where p-values were adjusted to 0.05/3 = 0.016, where three
stands for the number of between group comparisons.
The relationship between the results of the neuropsychological
tests and the size of the CNS structures were analyzed by Pearson
correlations. Correlations with the number of stages completed
in the PAL test were analyzed by Spearman Correlation, since
the distribution of this variable deviated largely from the normal
distribution.
RESULTS
Differences in Cortical Volumes, Cortical
Thickness and Cognitive Performance
between Subjects with amci, namci, and
Controls
A significant difference was found in the volume of the
hippocampus [F(2, 61) = 9.2, p = 0.0002] and in the volume
of the entorhinal cortex across study groups [F(2, 61) = 4.3,
p = 0.02]. The post hoc tests showed that the volumes are
significantly decreased in the aMCI group relative to the controls
and to the naMCI group, while the other two groups did not
differ significantly (Table 3 and Figure 1) Among the covariates,
gender had a significant effect on the volume of the hippocampus,
male subjects had a significantly decreased hippocampus size
relative to females [F(2, 61) = 7.9, p = 0.007].
The average thickness of the entorhinal cortex [F(2, 61) = 13.1,
p < 0.0001], the fusiform gyrus [F(2, 61) = 6.7, p = 0.002],
the isthmus of cingulated gyrus [F(2, 61) = 5.4, p = 0.007], and
the precuneus [F(2, 61) = 10.4, p = 0.0001] are also differed
significantly across the study groups. According to the post-hoc
tests, decreased cortical thickness were found in the aMCI relative
to the controls in all four structures, while the thickness of the
entorhinal cortex and the fusiform gyrus were also significantly
decreased in the aMCI group relative to the naMCI group. The
group means, the results of the post-hoc tests, and the between
group differences in terms of Cohen’s d are summarized in
Table 3.
There was a significant difference across study groups in
anterograde memory [F(2, 60) = 12.9, p < 0.0001], retrograde
memory [F(2, 60) = 6.1, p = 0.004], categorical fluency
[F(2, 60) = 22.9, p < 0.0001), and letter fluency [F(2, 60) =
4.9, p = 0.01]. In anterograde memory and categorical fluency
both the control group and the naMCI group outperformed the
FIGURE 1 | Between group differences in CNS structures and
neuropsychological tests. Vertical bars represent group means, while error
bars represent standard deviations. The horizontal lines over the vertical bars
indicate significant between group differences after correction for multiple
comparisons (p < 0.016). HC, healthy controls; aMCI, amnestic mild cognitive
impairment; naMCI, non-amnestic mild cognitive impairment; CNS, central
nervous system.
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TABLE 3 | Differences of the CNS structures and the neuropsychological test results between study groups.
Structure controls ( n = 24) naMCI ( n = 18) aMCI ( n = 20) Cohen’s d Cohen’s d Cohen’s d
Mean (SD) Mean (SD) Mean (SD) (HC vs. aMCI) (HC vs. naMCI) (naMCI vs. aMCI)
CORTICAL THICKNESSa
Entorhinal cortex 3.485 (0.236) 3.318 (0.255) 2.803 (0.640) 1.6* 0.7 1.2*
Fusiform gyrus 2.619 (0.158) 2.538 (0.169) 2.376 (0.252) 1.2* 0.5 0.8*
Isthmus of cingulate gyrus 2.287 (0.169) 2.178 (0.137) 2.103 (0.202) 1* 0.7 0.4
Parahippocampal gyrus 2.678 (0.317) 2.593 (0.331) 2.499 (0.438) 0.5 0.3 0.2
Posterior cingulate 2.380 (0.103) 2.385 (0.126) 2.332 (0.170) 0.4 0 0.4
Precuneus 2.210 (0.092) 2.101 (0.113) 2.029 (0.155) 1.5* 1.1* 0.5
VOLUMESb
Entorhinal cortex 0.328 (0.061) 0.345 (0.054) 0.285 (0.079) 0.6 −0.3 0.9*
Fusiform gyrus 1.701 (0.200) 1.631 (0.216) 1.556 (0.191) 0.7 0.3 0.4
Isthmus of cingulate 0.456 (0.046) 0.468 (0.043) 0.445 (0.051) 0.2 −0.3 0.5
Parahippocampal gyrus 0.383 (0.044) 0.394 (0.056) 0.367 (0.093) 0.2 −0.2 0.4
Posterior cingulate 0.578 (0.047) 0.604 (0.058) 0.586 (0.054) −0.2 −0.5 0.3
Precuneus 1.654 (0.104) 1.665 (0.143) 1.621 (0.154) 0.3 −0.1 0.3
Hippocampus 0.780 (0.044) 0.743 (0.094) 0.637 (0.156) 1.4* 0.5 0.8*
Amygdala 0.310 (0.024) 0.286 (0.035) 0.268 (0.069) 0.9* 0.8 0.3
NEUROPSYCHOLOGICAL TEST
ACE total scorec 94.000 (3.297) 89.111 (5.144) 82.211 (7.391) 2.2* 1.2 1.1*
ACE anterograde memoryd 26.000 (1.769) 24.556 (2.640) 20.842 (4.285) 1.7* 0.7 1.1*
ACE category fluencyd 6.542 (0.658) 5.889 (1.323) 3.947 (1.580) 2.3* 0.7 1.3*
ACE letter fluencyd 5.625 (1.096) 4.056 (1.830) 4.579 (1.427) 0.8 1.1* −0.3
ACE languaged 27.625 (0.711) 27.444 (1.338) 26.050 (6.211) 0.5 0.2 0.4
MMSEe 28.500 (1.351) 28.278 (0.958) 27.474 (1.679) 0.7 0.2 0.6
ACE Retrograde memoryd 3.708 (0.955) 3.222 (0.878) 2.421 (1.346) 1.1* 0.5 0.7
ACE Visuospatial functiond 4.792 (0.509) 4.389 (1.145) 4.421 (0.838) 0.6 0.5 0
Trail Making Test part A (sec) 41.917 (22.645) 59.222 (18.057) 75.650 (52.109) −0.9* −0.9 −0.5
Trail Making Test part B (sec) 68.542 (31.121) 153.18 (78.212) 199.74 (113.09) −2* −2* −0.5
HC, healthy controls; CNS, central nervous system; SD, standard deviation; aMCI, amnestic mild cognitive impairment; naMCI, non-amnestic mild cognitive impairment; ACE,
Addenbrooke’s cognitive examination; MMSE, Mini Mental State Examination.
aCortical thickness in mm.
bCortical volume in mm3.
cThe maximum score is 100.
dSubtasks of the ACE
eMaximum score is 30.The normative data can be found in the Table 2B.
*Significant between group difference after correction for multiple comparisons (p < 0.016). Level of significance was set to 0.05/3 = 0.016, where three stands for the number of the
study groups compared.
aMCI group, while the former groups did not differ significantly
(Table 3). In retrograde memory controls outperformed the
aMCI group, but not the naMCI group. In letter fluency controls
outperformed the naMCI group, but not the aMCI group, while
the two MCI groups did not differ from each other (p > 0.05).
Furthermore in categorical fluency female subjects performed
better than males [F(1, 60) = 9.8, p = 0.003], while age had no
significant effect on the performance.
Correlational Analyses
In the entire sample strong correlation were found between
the results of the neuropsychological tests and the volume and
thickness of the temporal brain structures (Table 4).
In the aMCI group the result of the Rey Verbal Learning
Test showed a significant positive correlation with the size
of the amygdala (r = 0.47, n = 20, p = 0.03), and
the thickness of the entorhinal cortex (r = 0.46, n = 20,
p = 0.04; Figure 2). Subjects with decreased amygdala volumes
and decreased entorhinal thickness showed poorer performance
on the memory test.
Furthermore subjects with decreased entorhinal volumes
(r = 0.49, n = 19, p = 0.03), and decreased fusiform gyrus
volumes (r = 0.48, n = 19, p = 0.04) and fusiform cortical
thickness (r = 0.53, n = 19, p = 0.02) performed weaker in the
retrograde memory subtest of the ACE.
DISCUSSION
Amnestic and non-amnestic MCI were assigned as potential
prodromes to different types of NCDs. Subjects with amnestic
mild cognitive impairment are assumed to have a higher
risk of converting to Alzheimer’s dementia, while subjects
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TABLE 4 | Correlations between the CNS structures and the neuropsychological test results across the entire sample.
Structure RAVLT items 1-5 sum (n = 62)
Pearson r (p-value *)
ACEa Total Score (n = 61)
Pearson r (p-value *)
Trail Making Test part B
(n = 60) Pearson r (p-value *)
Stages Completed in the
PALb test (n = 49) Spearman r
(p-value *)
CORTICAL THICKNESS (IN mm)
Entorhinal cortex 0.60 (p ≤ 0.001) 0.58 (p ≤ 0.001) 0.20 (p = 0.129) 0.47 (p ≤ 0.001)
Fusiform gyrus 0.52 (p ≤ 0.001) 0.53 (p ≤ 0.001) 0.29 (p = 0.026) 0.37 (p = 0.008)
Isthmus of cingulate gyrus 0.40 (p = 0.001) 0.37 (p = 0.004) 0.34 (p = 0.008) 0.23 (p = 0.109)
Parahippocampal gyrus 0.32 (p = 0.010) 0.28 (p = 0.027) 0.14 (p = 0.269) 0.24 (p = 0.098)
Posterior cingulate 0.30 (p = 0.020) 0.32 (p = 0.012) 0.24 (p = 0.070) 0.24 (p = 0.100)
Precuneus 0.48 (p ≤ 0.001) 0.44 (p ≤ 0.001) 0.40 (p = 0.001) 0.35 (p = 0.013)
VOLUMES (IN mm3)
Entorhinal cortex 0.31 (p = 0.013) 0.36 (p = 0.004) 0.12 (p = 0.342) 0.19 (p = 0.194)
Fusiform gyrus 0.28 (p = 0.030) 0.37 (p = 0.004) 0.29 (p = 0.027) 0.34 (p = 0.015)
Isthmus of cingulate 0.01 (p = 0.955) 0.04 (p = 0.752) 0.16 (p = 0.234) 0.09 (p = 0.543)
Parahippocampal gyrus 0.22 (p = 0.082) 0.25 (p = 0.053) 0.01 (p = 0.959) 0.14 (p = 0.353)
Posterior cingulate 0.13 (p = 0.308) 0.18 (p = 0.168) 0.30 (p = 0.020) 0.19 (p = 0.182)
Precuneus 0.02 (p = 0.890) 0.07 (p = 0.583) 0.24 (p = 0.065) 0.14 (p = 0.320)
Hippocampus 0.50 (p ≤ 0.001) 0.51 (p ≤ 0.001) 0.15 (p = 0.238) 0.43 (p = 0.002)
Amygdala 0.40 (p = 0.001) 0.45 (p ≤ 0.001) 0.06 (p = 0.623) 0.51 (p ≤ 0.001)
aACE = Addenbrooke’s cognitive examination (maximum score is 100).
bPAL test = Paired Associates Learning test.
*Significant between group differences after correction for multiple comparisons (p < 0.0125) are bolded. Level of significance was set to 0.05/4 = 0.0125, where four stands for the
number of the neuropsychological tests analyzed.
FIGURE 2 | Correlation between short term memory performance as indexed by the Rey verbal learning test and the amygdala volume and the
entorhinal cortex thickness in the study groups. Pearson correlations were significant (p < 0.05) in the amnestic MCI group and in the entire sample, while
non-significant in the control and in the non-amnestic MCI groups. Rey verbal test total score on the vertical axes equals the sum of words in the first five trials. red
line, regression line in the aMCI group; dashed line, regression line in the entire sample; MCI, mild cognitive impairment; r and p, Pearson correlation coefficient
adjusted for age and corresponding level of significance in the aMCI group.
with non-amnestic mild cognitive impairment are said to have a
higher risk of converting to non-Alzheimer’s dementia (Petersen
et al., 1999; Killiany et al., 2000; Petersen and Negash, 2008).
The structural differences of the brain were examined by
MRI in the MCI subgroups and healthy control group, while
the differences in cognitive performance were investigated by
neuropsychological tests. According to MRI results the thickness
of the entorhinal cortex, the fusiform gyrus, the isthmus of
cingular gyrus, and the precuneus, and the volume of the
amygdala and the hippocampus were decreased in aMCI relative
to healthy controls. These findings are in line with previous
studies reporting that healthy subjects, patients with MCI or
Alzheimer’s disease can be differentiated from each other based
on the volumes of the temporal lobe structures such as the
amygdala or the hippocampus (Desikan et al., 2009; McEvoy
et al., 2009).
The volumes of the hippocampus and the entorhinal cortex,
and the thickness of the entorhinal cortex and the fusiform gyrus
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are significantly decreased in the aMCI relative to the naMCI
group. The largest between group difference was detected in
the volume and thickness of the entorhinal cortex (0.9 and 1.2
SD, respectively), which is in line with the fact that atrophy in
AD starts in this region. These results show that there are early
structural differences between the subtypes of MCI. Furthermore
the pattern of these structural findings are fit to the pathology
of Alzheimer’s disease (Braak and Braak, 1991), which underline
those previous results that aMCI progress to Alzheimer disease
with a higher frequency relative to naMCI (Killiany et al., 2000;
Petersen and Negash, 2008).
Comparing the control and the naMCI group a significant
difference was only found in the thickness of the precuneus which
was decreased in the naMCI group. Interestingly a recent study
found white matter lesions in patients with naMCI also in the
precuneus (O’Dwyer et al., 2011), which is an important hub
sustaining information transfer between the parahippocampal
gyrus and the prefrontal cortex (Vincent et al., 2006) and plays
an important role in memory process and visual imaginary.
Among the neuropsychological tests, the MMSE did not
differ across study groups, which is a likely consequence of the
exclusion of patients with dementia. In the ACE total, ACE
anterograde memory, and ACE category fluency subtests the
aMCI group performed worse relative to the naMCI group and
the healthy control group. In the retrograde memory test of the
ACE and in the Trail Making A and B tests the aMCI group only
performed worse than the healthy controls, while no difference
was detected between the two MCI subgroups. The decreased
performance on the memory tasks (RAVLT and ACE retrograde
memory task) in the aMCI group correlated with the increased
involvement of temporal lobe structures such as the entorhinal
cortex, and the amygdala (Figure 2), which further confirms our
results on between group differences.
In the letter fluency task the naMCI group performed worse
than the healthy group, while the aMCI did not differ from
the other groups. Trail making B test is an index of visual
attention and task switching. The decreased performance of both
MCI groups relative to controls (Table 3) is likely the result
of frontal involvement. Both category and letter fluency tasks
rely strongly on the functioning of the frontal lobe, including
executive processes that require subjects to organize retrieval,
monitor responses previously recalled, initiate verbal responses
and inhibit responses that do not fit within the criteria (Henry
et al., 2004). “Both measures also access semantic memory stores,
a function of the temporal lobe; although letter fluency appears
to tap this ability linked to temporal lobe to a lesser extent than
category fluency” (Lezak et al., 2004). Lesion and functional brain
imaging studies also support the involvement of the temporal and
frontal lobes in fluency ability. Previous fMRI studies showed that
Letter fluency is associated with increased activation in the frontal
lobes, while both the frontal and temporal lobes are active during
category fluency (Birn et al., 2010). This corresponds well with
our findings that aMCI differs significantly according to category
fluency in comparison with healthy and naMCI group, while
there is no significant difference between the two subgroups in
the letter fluency result.
Strong correlations were found between verbal and visual
memory functions as indexed by the RAVLT and the PAL tests,
and the volumes and cortical thickness of the temporal structures
such as the entorrhinal cortex (Table 4) in the entire sample and
also in the aMCI group (Figure 2). These findings cross validate
the usefulness of these neuropsychological and MRI markers in
the early diagnosis of pathological cognitive decline and in the
monitoring of disease progression.
Limitations
A limitation of the study is that the majority of the subjects in the
aMCI group were multi-domain type, since their performance in
executive functions as assessed by the trail making test B and the
ACEwere under the normal range. This limitation taken together
with the fact that naMCI is a more heterogeneous entity relative
to aMCI may explain why the current study was not able to find
CNS structures with decreased size in the naMCI group relative
to the aMCI group.
CONCLUSIONS
The naming of aMCI and naMCI are not just theoretical but these
subtypes are different entities both from a neuropsychological
and from a brain structural viewpoint. The development of
specific MRI and neuropsychological criteria for the different
subtypes of mild cognitive impairment will then make it possible
to assess the determinants and the prevalence of the MCI
subtypes.
The assignment of MCI subtypes will be useful to improve
the prediction of dementia type and the risk of conversion to
dementia. Furthermore the assignment of MCI subtypes may
provide a better approach to testing the efficacy of therapeutic
options in preventing the conversion to neurocognitive
disorders. Based on our results MRI can be a useful tool to the
more precise separation between MCI subtypes.
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